Utah to Ban Sale of Flavored E-cigarettes and Disposable Devices from Jan 2025

Regulations by 2FIRSTS.ai
Mar.22.2024
Utah to Ban Sale of Flavored E-cigarettes and Disposable Devices from Jan 2025
Utah Governor Spencer Cox signed a bill banning the sale of flavored e-cigarette products. The bill prohibits the sale of flavored e-cigarette cartridges and disposable devices, specifically targeting flavors such as fruit, candy, dessert, alcoholic beverages, spices, or mint. The ban will take effect on January 1, 2025.

According to abc4 reports on March 21, this Wednesday (March 20), Utah Governor Spencer Cox signed a bill banning the sale of flavored e-cigarette products in Utah.

 

Senate Bill 61 prohibits the sale of flavored e-cigarette cartridges and disposable devices, specifically targeting flavors such as fruit, candy, dessert, alcoholic beverages, spices, or mint. Mint and tobacco flavors will still be allowed. The ban will take effect on January 1, 2025.

 

The sponsor of the bill, Democratic Senator Jen Plumb, stated that the legislation aims to curb the popularity of flavored e-cigarettes among adolescents.

 

Initially, the bill included mint as an allowed flavor, but it was removed at the last minute when the agreement was reached. Plumb stated that the bill is not intended to cause traditional tobacco shops to go out of business but rather, "if we ban flavors, businesses will have to change their models."

 

However, Republican Senator Todd Weiler opposes the bill, believing that it will harm the hundreds of traditional tobacco shops that have emerged in Utah in recent years because these tobacco shops are the only places where flavored e-cigarette products can be sold. Last month, many protesters gathered outside the Capitol to oppose the bill, with protesting adults stating that they enjoy flavored e-cigarette products and that these products can help them quit more harmful cigarettes.

 

In addition to banning flavored e-cigarette products, the bill also prohibits the sale of any e-cigarette products not authorized by federal officials.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
Report Says Teen e-cigarette use on the rise, with majority of sales coming from disposable products
Report Says Teen e-cigarette use on the rise, with majority of sales coming from disposable products
Monitoring a Changing Tobacco Product Market in the United States is the second annual review from the Monitoring Tobacco Product Use project, analyzing retail scanner data from January 2019 to December 2024 and TEEN+ survey data.
Jan.07 by 2FIRSTS.ai
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s appeal court again sides with KT&G, Philip Morris Korea and BAT Korea in $36.24 million case
South Korea’s National Health Insurance Service (NHIS) has again lost on appeal in its damages lawsuit against KT&G, Philip Morris Korea and BAT Korea, seeking ₩53.3 billion (about $36.244 million).
Jan.15 by 2FIRSTS.ai
First Prosecution in Singapore Over Social Media Vaping Posts
First Prosecution in Singapore Over Social Media Vaping Posts
A 25-year-old man in Singapore has been fined for posting videos and photos of himself holding or using e-vaporisers on social media platforms. The case marks the first prosecution by the Health Sciences Authority for such online content.
Dec.18 by 2FIRSTS.ai
UK Guernsey's QuitVape program for youth e-cigarette cessation to end at the end of the month
UK Guernsey's QuitVape program for youth e-cigarette cessation to end at the end of the month
QuitVape e-cigarette quitting service for teens in Guernsey to end this month, after six-month trial period.
Dec.29 by 2FIRSTS.ai
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
Product | ON! PLUS: Breakdown of Six FDA-PMTA-Authorized Nicotine Pouches—6/9 mg Strengths, Slim Format, and Traditional Flavours
The U.S. FDA has added six ON!® PLUS nicotine pouch products to its list of Marketing Granted Order (MGO) authorizations. Based on 2Firsts’ review, the approved products feature a highly standardized configuration in terms of format, nicotine strength, and flavour portfolio, primarily focusing on 6 mg and 9 mg strengths and traditional variants such as mint, wintergreen, and tobacco—reflecting a clear compliance-oriented approach.
Dec.22 by 2FIRSTS.ai